Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Remuzzi

Showing results (541-550 of 546) with videos related to

Pageof 55
Sort By:
You have reached the last page of results.This site can display upto 546 results.
Transplantation|December 16, 2000
Risk of nonmelanoma skin cancer in Italian organ transplant recipients. A registry-based studyL Naldi, A B Fortina, S Lovati, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 2, 2007
Successful liver-kidney transplantation in two children with aHUS caused by a mutation in complement factor HH Jalanko, S Peltonen, A Koskinen, et al.
Transplantation Proceedings|June 21, 2005
Blood cyclosporine level soon after kidney transplantation is a major determinant of rejection: insights from the Mycophenolate Steroid-Sparing TrialE Gotti, N Perico, F Gaspari, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|April 23, 2002
The losartan renal protection study--rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan)B M Brenner, M E Cooper, D de Zeeuw, et al.
Annals of Internal Medicine|July 17, 2001
Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level dataT H Jafar, C H Schmid, M Landa, et al.
The New England Journal of Medicine|June 7, 2013
Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndromeC M Legendre, C Licht, P Muus, et al.
Pageof 55

Showing results (541-550 of 546) with videos related to

Sort By:
Pageof 55
You have reached the last page of results.This site can display upto 546 results.
Transplantation|December 16, 2000
Risk of nonmelanoma skin cancer in Italian organ transplant recipients. A registry-based studyL Naldi, A B Fortina, S Lovati, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 2, 2007
Successful liver-kidney transplantation in two children with aHUS caused by a mutation in complement factor HH Jalanko, S Peltonen, A Koskinen, et al.
Transplantation Proceedings|June 21, 2005
Blood cyclosporine level soon after kidney transplantation is a major determinant of rejection: insights from the Mycophenolate Steroid-Sparing TrialE Gotti, N Perico, F Gaspari, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|April 23, 2002
The losartan renal protection study--rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan)B M Brenner, M E Cooper, D de Zeeuw, et al.
Annals of Internal Medicine|July 17, 2001
Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level dataT H Jafar, C H Schmid, M Landa, et al.
The New England Journal of Medicine|June 7, 2013
Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndromeC M Legendre, C Licht, P Muus, et al.
Pageof 55